Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy
- 1 October 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 60 (4) , 1297-1308
- https://doi.org/10.1046/j.1523-1755.2001.00935.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathyKidney International, 2000
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJournal of Clinical Investigation, 1999
- A new model of renal microvascular endothelial injuryKidney International, 1997
- Hemolytic Uremic Syndromes in ChildhoodSeminars in Thrombosis and Hemostasis, 1997
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurityNature Medicine, 1995
- The hemolytic uremic syndromeKidney International, 1995
- Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.Journal of Clinical Investigation, 1995
- Outcome and Prognostic Determinants in the Hemolytic Uremic Syndrome of ChildrenNephron, 1994
- Recent Advances in the Expression of Foreign Genes in Pichia pastorisNature Biotechnology, 1993